Baicalein Complete Guide: Source, Process, Testing, and Selection

Part of Complete Guide to Scutellaria baicalensisHerb Wiki Editorial TeamCAS 491-67-8Last updated 2026-10-29

CAS No.491-67-8
Molecular formulaC15H10O5
Relative molecular mass270.24
AppearancePale yellow to yellow needle crystals or powder
Melting point256–271 ℃ (literature range)
AssayBaicalein 90%–98% (HPLC, on a dried basis)
Common specifications90%, 95%, 98%
Test methodHPLC-UV 274 nm or 280 nm, methanol-0.1% phosphoric acid water (~55∶45)

Definition in One Sentence

Baicalein is one of the main flavonoid constituents of the dried root of Scutellaria baicalensis Georgi (Lamiaceae). Its chemical name is 5,6,7-trihydroxyflavone, molecular formula C15H10O5, molecular weight 270.24, CAS 491-67-8. It is the aglycone of baicalin, obtained industrially by hydrolysis and purification of Scutellaria root extract, supplied at 90%–98% grade, and used as a pharmaceutical intermediate, functional ingredient, cosmetic raw material, and research reference standard.

Chemical Identity: Align the Name Before Discussing Price

Baicalein structure
Fig. 1 Baicalein structure: the aglycone after removal of glucuronic acid from baicalin (C15H10O5). Placeholder image, to be replaced with a real/illustrated asset.
ItemContent
Standard Chinese nameBaicalein (alias: baicalein aglycone)
Chemical name5,6,7-trihydroxyflavone
English nameBaicalein
CAS No.491-67-8
Molecular formulaC₁₅H₁₀O₅
Molecular weight270.24
Compound classPolyhydroxyflavone (flavone)
Botanical originScutellaria baicalensis Georgi dried root
OriginFuping, Weinan, Shaanxi (Weibei dry plateau, own cultivation base)
AppearancePale yellow to yellow needle crystals or powder
SolubilitySoluble in organic solvents such as methanol, ethanol, acetone; poorly soluble in water; soluble in alkaline solution
Melting pointLiterature reports mostly in the 256–271 ℃ range
Common specifications90%, 95%, 98% (HPLC)

1.1 Three Easily Confused "Neighbors"

Baicalin (CAS 21967-41-9): the 7-O-glucuronide of baicalein, the truly "most abundant" constituent in Scutellaria herb and the pharmacopoeial marker. Molecular weight 446.36; water solubility improves markedly with the glucuronic acid group. The relationship is "aglycone and glycoside": the plant is dominated by baicalin, while commercial baicalein is the hydrolysis product.

Wogonin (CAS 632-85-9): also a Scutellaria flavone, differing by 8-methoxy substitution. Pharmacological direction is similar but not identical; content is usually far lower than baicalein and it often appears as a related substance of baicalein in the impurity profile.

Huangqisu (misnomer): "Baicalein" miswritten as "Huangqisu" is a frequent error in Chinese searches and inquiries. Baicalein comes from Scutellaria; Astragalus's marker is astragaloside IV (CAS 84687-43-4, a triterpene saponin). One is a flavone, the other a saponin—their pricing and testing systems are completely different. Contracts and technical documents must be based on the CAS number.

Source and Assay Basis: An Account You Can Verify Yourself

Aglycone from glycoside: hydrolysis
Fig. 2 Baicalin releases glucuronic acid under enzymatic/acid hydrolysis to form baicalein, with a theoretical mass yield of 60.5%. Placeholder image, to be replaced with a real/illustrated asset.

The Chinese Pharmacopoeia 2025 edition (Volume I) stipulates that Scutellaria herb, calculated on a dried basis, must contain no less than 9.0% baicalin (C21H18O11). Free baicalein in the herb is very low; commercial baicalein is almost entirely obtained by hydrolysis of baicalin, so the baicalin content of the herb directly sets the upper limit of baicalein yield.

The mass conversion of hydrolysis can be calculated precisely: baicalin (446.36) loses one molecule of glucuronic acid (176.12) to yield baicalein (270.24), giving a theoretical mass yield of 270.24 ÷ 446.36 ≈ 60.5%.

This gives a material-balance line:

  • 1 tonne of qualified herb (baicalin at 9.0%) contains about 90 kg baicalin;
  • complete hydrolysis theoretically yields about 54 kg baicalein;
  • including extraction loss, hydrolysis side reactions, and purification yield (overall estimated at 40%–60%), actual output is about 22–32 kg;
  • that is, producing 1 kg of 98% baicalein requires a theoretical feed of about 30–45 kg herb.

Any quote that deviates significantly from this line—whether absurdly high or low—warrants first asking about the raw-material baicalin content and the hydrolysis process.

2.3 Origin and Authenticity: Fuping, Weinan, Shaanxi

Scutellaria is mainly produced in Hebei, Shanxi, Shaanxi, Gansu, Inner Mongolia, and elsewhere. Our raw material comes from the Weibei dry plateau of Laomiao Town, Fuping County, Weinan City, Shaanxi Province—a Piedmont dry tableland at the southern foot of the Qiao Mountains, dominated by loess soil, a high-quality suitable growing area for commercial Scutellaria.

The most noteworthy of this region is a set of public data: the baicalin content of Scutellaria produced in Laomiao, Fuping is reported in the 12%–16% range (Weinan Daily reported over 16% in 2025, and an enterprise test in the production area in 2016 was 12%), while the Chinese Pharmacopoeia lower limit is 9.0%. The content difference translates directly into cost: each 1 percentage point higher in baicalin yields about 6 kg more baicalein per tonne of herb at the same feed.

Three conditions in this area are favorable for Scutellaria:

  • Light and temperature difference: long annual sunshine hours and large diurnal temperature difference favor the accumulation of secondary metabolites. It is widely believed in production that baicalin accumulation in the root is more stable under such conditions, but batch-by-batch testing remains the final basis.
  • Soil: loess sandy loam, deep soil layer and good drainage, matching Scutellaria's preference for "cool and dry, averse to waterlogging"; roots are straight with few fibrous roots, giving better commercial appearance after peel-rubbing.
  • Moisture: annual precipitation about 500–600 mm, mainly dryland management, little waterlogging, low root-rot risk.

Harvest per the Chinese Pharmacopoeia requirement in spring and autumn, remove fibrous roots and soil, sun-dry then rub off the coarse bark and dry. In practice the production area harvests mainly in autumn, with concentrated lifting after Frost's Descent; growth period 2.5–3 years, fresh herb yield about 600–800 kg per mu. It is generally held in production that roots grown about 3 years and harvested in late autumn accumulate baicalin better; but this is only local experience and does not constitute a quality commitment—actual testing data is the sole basis.

The accurate statement on "Daodi": Fuping is not a traditional Daodi region in historical texts, but its core cooperative was listed in 2021 as a first-batch "Shaanxi Provincial Authentic Medicinal Herb Cultivation Demonstration Base" construction unit and received the "Shaanxi Provincial Customized Medicinal Garden" title. In promotion, the verifiable "provincial authentic medicinal herb cultivation demonstration base" should be used rather than loosely calling itself "Daodi herb"—the former has certification documents, the latter is a quality claim.

Practical significance for procurement: baicalein of the same specification from different origins may match in assay but often differs in color and impurity profile—this comes from the secondary-metabolite background of the raw material, not a process defect. Requiring suppliers to provide the origin-to-batch correspondence controls risk better than price comparison alone. Our raw material comes from Fuping's own base and cooperative contract farming, with batches traceable to the plot and harvest season; see Complete Guide to Fuping Scutellaria baicalensis: Origin and Cultivation Base.

Production Process: From Scutellaria Root to 98% Isolate

The industrial preparation of baicalein isolate revolves around three stages—"extract glycoside, hydrolyze, purify"—from Scutellaria root to 98% finished product, each step corresponding to a class of impurities to control.

  1. Extraction: Scutellaria root is extracted by boiling-water decoction or dilute alcohol; baicalin transfers to the aqueous phase. Industrially, boiling water is commonly used to inactivate the plant's native β-glucuronidase, preventing premature hydrolysis and conversion of the constituents during extraction.
  2. Acid precipitation purification: the extract is acidified and baicalin precipitates, yielding crude baicalin (this is also the mainstream production method for commercial baicalin).
  3. Hydrolysis conversion: the crude product is hydrolyzed in an acidic aqueous system (or an enzymatic β-glucuronidase system); the sugar chain is cleaved to give baicalein. The acid method is low-cost and thorough; the enzymatic method is milder with a cleaner impurity profile but costs more.
  4. Purification: recrystallization or column chromatography to decolorize and remove impurities, upgrading the 90% grade to 95% and 98%.
  5. Drying and sieving: vacuum drying, passing 80 mesh (some customers require 100 mesh).

Implications for the buyer: poorly controlled acid hydrolysis can leave sulfate/chloride residues and deepen color; a high baicalin residue in the impurity profile indicates incomplete hydrolysis. When reviewing a 90% batch report, these two items reflect process level better than the assay number itself.

Testing: HPLC-UV Is Enough, but You Must Read the Report

4.1 Method Essentials

Baicalein has a flavone conjugated system with strong absorption in the UV region; routine HPLC-UV (~274–280 nm, C18 column, methanol/acetonitrile-water-phosphoric acid system) gives accurate quantification, with mature methodology and low cost. This is in sharp contrast to saponins such as astragaloside IV that have no UV absorption and require an evaporative light-scattering detector. For high-purity isolates and impurity-profile studies, LC-MS can be added for confirmation.

4.2 Data from a Real Batch (Our Batch Example)

Test itemStandardMeasured (Batch No. 2026091201)
Assay≥90%90.12%
AppearancePale yellow powderPale yellow powder, conforms
SolubilityFully soluble in methanol, ethanol, acetoneConforms
Particle size100% passes 80 meshConforms
Moisture≤5%2.36%
Heavy metals≤10 ppmConforms
Lead (Pb)≤1.0 ppmConforms
Arsenic (As)≤1.0 ppmConforms
Total bacteria<1000 cfu/g<100 cfu/g
ColiformsNot detectedNot detected
SalmonellaNot detectedNot detected

Production date 2026-09-12, inspection date 2026-09-13. This batch is a typical "commercial-grade 90% specification": ample margins for microorganisms and heavy metals, assay hugging the lower limit—which is the normal shape of the 90% grade; the specification-selection section below explains why you need not pay extra for it.

4.3 Items Not on This COA but Expected in a More Complete Report

  • Cadmium (Cd), mercury (Hg): testing only lead and arsenic but not cadmium and mercury means heavy-metal control is incomplete;
  • Ash / ignition residue: reflects inorganic residues;
  • Related substances: baicalin residue (direct evidence of incomplete hydrolysis), wogonin and other flavone impurities;
  • Residual solvents: if organic solvents are used in purification;
  • Batch assay-to-chromatogram correspondence: the assay number must trace to a specific chromatogram.

For the test method and interpretation essentials of each item, see Baicalein Specifications and Test Methods Explained.

Grade Selection: Above 90%, Every Step Pays a Non-linear Premium for Purity

Specification (HPLC)Typical formSuitable applicationsKey point
90%Pale yellow powderCosmetic raw material, feed and veterinary drugs, ingredient-grade health foodMain commercial grade, best cost-performance; impurity profile dominated by baicalin residue
95%Pale yellow powderHighly standardized formulations, export gradeOne more purification round, lighter color
98%Yellow needle crystalsResearch reference standard, pharmaceutical intermediate, injectable-grade researchRequires recrystallization, large yield loss, small single-batch size

The order of baicalein grade selection is fixed—first set the test basis and impurity requirements, then the grade, then compare prices; doing it backwards, the money saved at the quoting stage is paid back at acceptance. For the 98% grade, beyond assay you should request the related-substance profile and LC-MS confirmation.

Pharmacology and Mechanisms: Read by Level of Evidence

Baicalein has a very rich body of in vitro research, but human clinical evidence is generally limited; a clear mechanism does not equal clinical efficacy.

Anti-inflammatory (12/15-lipoxygenase inhibition) (in vitro, classic)

Baicalein is a classic 12-LOX and 15-LOX inhibitor in the literature, and suppresses COX-2 expression, reducing the leukotriene and prostaglandin cascades—this is the clear mechanistic point that distinguishes it from the "pan-antioxidant" narrative of most flavonoids.

Antioxidant (in vitro + animal, fairly substantial)

The polyhydroxy structure directly scavenges free radicals and upregulates the Nrf2/HO-1 pathway. Note: in aqueous systems baicalein itself is prone to oxidation, so the interpretation of some "antioxidant" experiments requires caution.

Antiviral (mainly in vitro)

There are multiple in vitro studies against influenza virus, HBV, and coronavirus main protease; it is far from druggability and must not be used as a promotional claim.

Neuroprotection (mainly animal models)

Related to suppressing neuroinflammation and reducing oxidative damage; blood-brain-barrier permeability is limited by solubility and metabolism.

Anti-tumor (in vitro + animal)

Shows proliferation inhibition and apoptosis induction in multiple tumor cell lines, with mechanisms involving topoisomerase, PI3K/Akt, and other pathways; clinical translation evidence is limited.

Hepatoprotection and anti-fibrosis (animal models)

Improves liver-injury and fibrosis models through the NF-κB and TGF-β/Smad pathways, a relatively concentrated area of research in traditional Chinese medicine.

Compliance reminder: the above mechanisms must not be rewritten as disease-treatment claims. Health-food claims are limited to approved function ranges, and cosmetic claims to filed efficacy ranges.

Pharmacokinetics and Stability: The Real Difficulty on the Formulation Side

After oral administration, baicalein undergoes rapid phase II glucuronidation in the intestinal epithelium and liver; the main form in circulation is its glucuronide conjugate (i.e., the baicalin form), with marked enterohepatic recirculation, and the literature reports generally low absolute bioavailability. The practical implication is that in vitro active concentrations cannot be directly extrapolated to oral doses; efficacy evaluation must measure the plasma conjugate form, not only the prototype.

Stability constraints

  • Poor water solubility: aqueous systems require solubilization (cyclodextrin inclusion, solubilizers, nano-dispersion);
  • Unstable under alkaline conditions: rising pH accelerates degradation; aqueous products containing baicalein should specify the pH control range in the quality standard;
  • Strong light and high temperature accelerate oxidative discoloration: pale yellow powder deepening in color after storage is common; store protected from light, sealed, and in a cool place;
  • Can complex with metal ions: contact with excipients or packaging containing aluminum, iron, and other ions may cause discoloration and assay loss; compatibility testing should be done during formulation screening.

Applications

Baicalein's downstream uses can be arranged on a purity gradient: pharmaceutical intermediates and research reference standards need 98% isolate; health food and cosmetics concentrate at 90%–95%; oral care, veterinary drugs, and feed have the lowest requirements for isolate purity.

  • Pharmaceutical intermediate: starting material for baicalein-containing preparations and derivative synthesis; focus on related substances and residual solvents.
  • Health food / functional ingredient: antioxidant and auxiliary protection directions, mainly the 90%–95% grade.
  • Cosmetics: a common botanical active for anti-acne, soothing, and antioxidant claims; raw materials should use the Scutellaria baicalensis-related standard name from the Inventory of Existing Cosmetic Ingredients.
  • Oral care and daily chemicals: leveraging its antibacterial and anti-inflammatory properties.
  • Veterinary drugs and feed: Scutellaria-extract-type products, usually no need to pursue high isolate purity.
  • Research reference standard: 98% isolate paired with batch-by-batch chromatograms and LC-MS confirmation.

Safety and Regulatory Status

Baicalein has low acute toxicity, with no obvious target-organ toxicity in animal studies, but long-term high-dose human data are limited.

Regulatory note (verify against the latest texts; not compliance advice):

  • China: Scutellaria is currently not listed in the "substances that are both food and traditional Chinese medicinal materials" catalog; use in ordinary food requires caution, and directly claiming food-grade is not recommended; health-food use follows registration/filing requirements; cosmetic use follows the standard name in the ingredient catalog. Herb and decoction pieces are managed by pharmacopoeial standards.
  • EU: Scutellaria baicalensis root extract is used in both food supplements and cosmetics; specific categories and processes may involve Novel Food assessment, to be confirmed by the target member state.
  • US: generally managed under the dietary supplement (DSHEA) framework; new-process specifications may trigger NDI notification obligations.

The conclusion remains: any change in specification, process, or market can change the compliance conclusion.

Procurement and QC Checklist

Baicalein procurement QC rests on two checklists: the nine mandatory COA items decide whether the report can be accepted, and the five common risk points decide what to check further after the report is complete.

10.1 Nine Mandatory COA Items

  1. Assay method and detection wavelength (HPLC-UV, ~274–280 nm);
  2. Assay grade and margin above the lower limit (batches near the limit need chromatogram review);
  3. Related substances: baicalin residue, wogonin, and other impurities;
  4. Botanical origin and part (Scutellaria baicalensis root);
  5. Moisture (this batch 2.36%, indicating good drying control);
  6. Heavy metals four items (Pb, As, Cd, Hg); if only two are given, request the rest;
  7. Microbial three items (total plate count, coliforms, Salmonella);
  8. Residual solvents (when organic-solvent purification is involved);
  9. Batch number, production/inspection dates, and chromatogram attachments.

10.2 Five Common Risk Points

  • Aglycone-glycoside mislabeling: selling baicalin (cheap, water-soluble) as baicalein, or labeling "total Scutellaria flavones" as the isolate;
  • Incomplete hydrolysis: high baicalin residue; assay number meets spec but impurity profile is poor;
  • Discolored batches: low-price clearance goods oxidized by improper storage;
  • Confused origin: substitution of Scutellaria by other species of the same genus;
  • Missing chromatograms: only numbers given without chromatograms, or chromatograms that do not match the batch number.

The response is to require chromatograms, require related substances, require batch-by-batch correspondence, and have key items re-tested by a third party. For the complete method of supplier screening and contract clauses, see Baicalein Procurement Guide.

Frequently Asked Questions

Q1: What is the relationship between baicalein and baicalin?

Aglycone and glycoside. Scutellaria herb is dominated by baicalin; commercial baicalein is the product after baicalin hydrolyzes off glucuronic acid, with molecular weight changing from 446.36 to 270.24.

Q2: Is baicalein the same as "Huangqisu"?

No. "Huangqisu" is a frequent miswriting of "baicalein", and Astragalus's marker is astragaloside IV (CAS 84687-43-4), completely unrelated to baicalein (CAS 491-67-8). Go by CAS number.

Q3: What is the difference between baicalein and wogonin?

Wogonin is the 8-methoxy substituted homolog; the two often coexist in Scutellaria extracts. Their pharmacological directions are similar but they are not the same substance and should be reported separately in the impurity profile.

Q4: Is baicalein water-soluble?

Poorly soluble in water; soluble in methanol, ethanol, acetone. Aqueous formulations require solubilization or inclusion, with separate stability validation.

Q5: Why is the price gap between 90% and 98% large?

Going from 90% to 98% adds recrystallization and chromatographic purification, with large yield loss and small single-batch size, so cost rises non-linearly. 90% is the main commercial grade; most applications need not pay a premium for 98%.

Q6: Why does baicalein discolor over time?

Polyhydroxyflavones oxidize easily; light, high temperature, and alkaline conditions accelerate it. Pale yellow is the normal appearance; marked darkening indicates storage or process problems.

Q7: How is baicalein absorbed orally?

Absolute bioavailability is low, mainly due to intestinal phase II glucuronidation metabolism and first-pass effect; the blood is dominated by conjugated forms. On the formulation side, exposure is raised through dosage-form design, not just piling up labeled content.

Q8: How to judge whether a COA is trustworthy?

Four checks: whether the method and wavelength are stated, whether related substances (baicalin residue) are reported, whether the heavy metals are all four items, and whether the chromatogram matches the batch number.

Q9: Can baicalein be used in ordinary food?

Scutellaria is not in China's food-medicine substance catalog; ordinary food use requires caution; health food and cosmetics follow their respective regulations.

Q10: Is it normal for color and assay to vary slightly between batches of the same grade?

Normal. Plant-derived constituents are affected by origin, harvest, and process; variation of the 90% grade between 90% and 93% is common. The key is whether the lower limit is met and the inter-batch consistency trend.

References and Search Suggestions

  1. Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia (2025 edition, Volume I), "Scutellaria" monograph (baicalin limit and HPLC-UV method).
  2. Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia (2025 edition, Volume IV), General Chapter 0512 High Performance Liquid Chromatography.
  3. Baicalein pharmacology and pharmacokinetics review: PubMed search "baicalein"[Title/Abstract] AND review[pt], limited to the last five years.
  4. In vivo conversion of baicalein and baicalin: search baicalein AND (baicalin OR glucuronidation OR pharmacokinetics).

The 3rd and 4th items give search paths rather than specific citations; when the original text is needed, follow these searches to verify.

Disclaimer

This article is raw-material technical information intended for R&D, procurement, and quality personnel; it does not constitute medical advice, medication guidance, or compliance opinion. The assay, process, and regulatory information herein change with standard revisions; actual transactions and filings should follow the latest official standards, the contract between both parties, and third-party test reports.